UCL Cancer Institute


Dr Derralynn Hughes honoured by NHS National Institute for Health Research (NIHS) award

4 March 2016

Dr Derralynn Hughes…

Dr Derralynn Hughes, Senior Lecturer and Clinical Director of Haematology, Oncology and Palliative care, and her team have been recognised by the NIHS awards for recruiting the first patient to a global study looking into the treatment of lysosomal storage disorders (LSDs).

LSDs are a group of rare inherited disorders which cause abnormal storage of large molecules in various organ systems in the body. LSDs can cause deterioration in the function and structure of several organs such as the brain, skeleton, liver, kidneys, lungs, heart and spleen.

Dr Hughes, who leads research in the LSD unit based at the Royal Free Hospital, said: “This award is a testament to the Royal Free London’s commitment to world-leading research.

“The research and development department has created an environment that facilitates rapid, full approval and trial initiation. We have an international reputation in LSDs and are already treating patients with these rare disorders because of the quality of care we can give them.

“All this means we are able to make major contributions to clinical research such as getting the first patient onto the trial.”

Further information: